Related Experiment Videos
[Effect of clopheline on thrombocyte aggregation]
Kardiologiia
|May 1, 1988
Summary
Clopheline slightly increases platelet aggregation in healthy individuals, acting as a weak inducer. However, it competitively inhibits adrenaline
Area of Science:
- Pharmacology
- Hematology
- Biochemistry
Context:
- Platelet aggregation is a critical process in hemostasis and thrombosis.
- Understanding modulators of platelet function is essential for cardiovascular research.
- Clopheline's pharmacological effects on blood cells require detailed investigation.
Purpose:
- To investigate the impact of clopheline on platelet aggregation.
- To characterize clopheline's interaction with common platelet agonists like ADP and adrenaline.
- To determine if clopheline acts as an inducer or antagonist in platelet aggregation.
Summary:
- Clopheline was tested for its effects on spontaneous, ADP-induced, and adrenaline-induced platelet aggregation in normal donors.
- Results indicate clopheline acts as a weak inducer of platelet aggregation in the absence of other agonists.
- In the presence of adrenaline, clopheline demonstrates competitive antagonism, reducing adrenaline's aggregation-inducing effect.
Impact:
- This study clarifies clopheline's dual role in platelet aggregation.
- Findings contribute to understanding clopheline's potential cardiovascular effects.
- Provides insights into clopheline as a potential therapeutic agent or a drug with side effects impacting thrombosis.